Nortech Systems Inc: Form 10-Q for the period ended Sep 30, 2011
Filed with the SEC on Nov 4, 2011 and accepted by EDGAR at Nov 4, 2011, 10:44 ET.
Management's discussion and analysis
As filed, 15,774 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Overview:
We are a Wayzata, Minnesota based full-service Electronics Manufacturing Services (EMS) contract manufacturer of wire and cable assemblies, printed circuit board assemblies, higher-level assemblies and box builds for a wide range of industries. We provide value added services and technical support including design, testing, prototyping and supply chain management to customers mainly in the Aerospace and Defense, Medical, and Industrial Equipment markets. We maintain manufacturing facilities in Baxter, Bemidji, Blue Earth, Mankato, Merrifield, and Milaca, Minnesota; Augusta, Wisconsin; and Monterrey, Mexico.
Summary of Results:
In the third quarter we continued to see growth in revenue from our recent acquisitions offset in party by some shortfalls in sales and orders from our existing industrial customers. We attribute this to continued uncertainty in the overall economy and buyers being more cautious about placing orders and carrying excess inventory. For the quarter ended September 30, 2011, we reported net sales of $28.3 million compared to $26.0 million reported in the same quarter of 2010, a 9% improvement. For the nine months ended September 30, 2011, we reported net sales of $85.1 million compared to $72.4 million reported for the first nine months of 2010, an increase of 18%. Our 90-day backlog decreased 4% from the start of the quarter to $21.9 million as of September 30, 2011. This compares to $23.5 million for the same period last year.
Gross profit improved in the third quarter as a result of favorable product and service mix, along with cost and efficiency initiatives at our newly acquired operations. Our gross profit in the third quarter of 2011 was 11.6% compared to 11.1% in the third quarter of 2010. Gross profit in the first nine months of 2011 was 11.4% compared to 11.9% in the first nine months of 2010.
Income from operations totaled $0.4 million and $0.2 million for the three months ended September 30, 2011 and 2010, respectively. Income from operations totaled $1.0 million for the each of the nine months ended September 30, 2011 and 2010.
Net income for the third quarter of 2011 totaled $0.2 million or $0.07 per diluted common share. Net income for the nine months ended September 30, 2011 totaled $1.0 million or $0.35 per diluted common share; $0.4 million or $0.15 per diluted common share excluding the bargain purchase gain of $0.5 million, net of tax. Net income totaled $0.1 million and $0.4 million for the three and nine months ended September 30, 2010.
Our cash position improved in the third quarter as we extended terms with key suppliers. Cash provided from operating activities was $2.5 million in the third quarter of 2011. Cash used in operating activities for the nine months ended September 30, 2011 was $2.2 million compared to cash provided by operating activities of $1.6 million for the same nine month period in 2010.
(1.) Results of Operations:
The following table presents statements of income data as percentages of total net sales for the periods indicated:
| Three Months Ended September 30 2011 | 2010 | Nine Months Ended September 30 2011 | 2010 | |
|---|---|---|---|---|
| Net Sales | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of Goods Sold | 88.4 | 88.9 | 88.6 | 88.1 |
| Gross Profit | 11.6 | 11.1 | 11.4 | 11.9 |
| Selling Expenses | 3.2 | 3.0 | 3.2 | 3.2 |
| General and Administrative Expenses | 6.9 | 7.5 | 7.0 | 7.4 |
| Income from Operations | 1.5 | 0.6 | 1.2 | 1.3 |
| Bargain Purchase Gain | 0.0 | 0.0 | 0.9 | 0.0 |
| Other Income (Expense), Net | (0.5) | 0.2 | (0.5) | (0.3) |
| Income Before Income Taxes | 1.0 | 0.8 | 1.6 | 1.0 |
| Income Tax Expense | 0.3 | 0.3 | 0.5 | 0.5 |
| Net Income | 0.7% | 0.5% | 1.1% | 0.5% |
Net Sales:
We reported net sales of $28.3 million and $26.0 million for the three months ended September 30, 2011 and 2010, respectively, a 9% increase. Net sales for the nine months ended September 30, 2011 and 2010 were $85.1 million and $72.4 million, respectively, an 18% increase. The 2011 net sales were impacted by our two recent acquisitions which added $5.2 million and $15.9 million of net sales for the three and nine months ended September 30, 2011, respectively.
Net sales by industry markets for the three and nine month periods ended September 30, 2011 and 2010 are as follows:
| Three Months Ended September 30 | Nine Months Ended September 30 | |
|---|---|---|
| 2011 2010% | 2011 2010% | |
| (in thousands) | $$ Change | $$ Change |
| Aerospace and Defense | 3,774 3,930 (4) | 10,949 12,003 (9) |
| Medical | 8,503 7,004 21 | 24,293 18,965 28 |
| Industrial | 16,055 15,023 7 | 49,871 41,425 20 |
| Total Sales | 28,332 25,957 9 | 85,113 72,393 18 |
Net sales to our Aerospace and Defense customers for the three months ended September 30, 2011 were slightly lower than last year due to production delays. The decrease for the nine months ended September 30, 2011 was related to late approval of the Federal Government’s funding of 2011 defense programs. The increase in net sales to our Medical customers of $1.5 million for the three months ended September 30, 2011 was primarily due to growth in our existing customer base of $0.8 million and the Mankato acquisition which generated an additional $0.7 million in additional net sales. The increase in net sales to our Medical customers of $5.3 million for the nine months ended September 30, 2011 is primarily due to the
Mankato and Milaca acquisitions, which added $2.4 million and $2.6 million, respectively. The Mankato acquisition also positively impacted net sales to Industrial customers by $4.6 million and $11.4 million for the three and nine months ending September 30, 2011, respectively, offset by shortfalls to our existing Industrial customers being impacted by an overall uncertain economy.
Backlog:
Our 90-day order backlog as of September 30, 2011 was approximately $21.9 million, compared to approximately $22.8 million at the beginning of the quarter and $23.5 million at September 30, 2010. Backlog by industry market is shown below.
(in thousands)
| Backlog as of the Quarter Ended September 30 2011 | June 30% 2011 | Change | |
|---|---|---|---|
| Aerospace and Defense | $5,384 | $4,025 | 34 |
| Medical | 6,077 | 6,314 | (4) |
| Industrial | 10,438 | 12,445 | (16) |
| Total Backlog | $21,899 | $22,784 | (4) |
The overall 90 day backlog is down from the start of the quarter due to continued uncertainty in the economy, especially as it relates to our Medical and Industrial customers. Our Aerospace and Defense backlog has increased in the second half of the year as funding is now available to complete the 2011 defense projects.
Gross Profit:
Gross profit percentage for the three months ended September 30, 2011 and 2010 was 11.6% and 11.1% of net sales, respectively. Gross profit percentage for the nine months ended September 30, 2011 and 2010 was 11.4% and 11.9%, respectively. In the third quarter we started to see margin improvements due to favorable product mix, price adjustments and cost reduction initiatives which resulted in gross profit improvement over the first six months of 2011.
General and Administrative Expense:
Our general and administrative expenses were $2.0 million or 6.9% of net sales and $1.9 million or 7.5% of net sales for the three months ended September 30, 2011 and 2010, respectively. General and administrative expenses were $6.0 million or 7.0% of net sales and $5.4 million or 7.4% of net sales for the nine months ended September 30, 2011 and 2010, respectively. The increase in general and administrative dollars spent in 2011 is primarily attributed to additional personnel and related costs incurred as a result of our recent acquisitions. The decrease in general and administrative expense as a percent of net sales is due to the leveraging effect on the increased revenue.
Other Income (Expense):
Other expense for the three months ended September 30, 2011 was $0.1 million compared to other income of $0.1 million for the three months ended September 30, 2010. The increase in other expense relates primarily to higher interest expense and less miscellaneous income. Other income for the nine months ended September 30, 2011 was $0.3 million, while other expense for the nine months ended September 30, 2010 was $0.2 million. The other income for the first nine months of 2011 is primarily due to recognizing a bargain purchase gain of $0.8 million from the Mankato acquisition in the first quarter of 2011, offset in part by higher interest expense.
Income Taxes:
Our effective tax rate for the three and nine months ended September 30, 2011 was 35% and 31%, respectively, compared with 42% and 52% for the three and nine months ended September 30, 2010, respectively. The differences between federal income taxes computed at the federal statutory rate and reported income taxes for the three and nine months ended September 30, 2011 and 2010 are as follows:
| Three Months Ended September 30 2011 | 2010 | Nine Months Ended September 30 2011 | 2010 | |
|---|---|---|---|---|
| Statutory federal tax provision | $96,000 | $71,000 | $473,000 | $261,000 |
| State income taxes | 8,000 | 8,000 | 41,000 | 24,000 |
| Income tax credits | (20,000) | (2,000) | (52,000) | (6,000) |
| NOL carryback true up | — | — | 111,000 | |
| Tax authority closing agreement | — | — | (96,000) | — |
| Reserve for uncertain tax positions | 5,000 | — | 95,000 | — |
| Other | 9,000 | 16,000 | (26,000) | 8,000 |
| Income tax expense | $98,000 | $93,000 | $435,000 | $398,000 |
Liquidity and Capital Resources:
We have satisfied our liquidity needs over the past several years through revenue generated from operations and an operating line of credit through WFB. We also have real estate and equipment term loans. Both the line of credit and real estate term note are subject to fluctuations in the LIBOR rates. The line of credit, real estate term note, and equipment loans with WFB contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures. The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender. The line of credit is secured by substantially all of our assets. On September 30, 2011, we had an outstanding balance of $9.3 million under the line of credit and unused availability of $4.0 million supported by our borrowing base. We also have $1.0 million available under a 2011 capital expenditure term loan agreement. We believe our financing arrangements and cash flows provided by operations will be sufficient to satisfy our future working capital needs.
Our working capital of $11.8 million as of September 30, 2011 decreased from $13.1 million at December 31, 2010 mainly due to increased usage of our line of credit and current maturities of long term debt of $4.9 million and increased accounts payable and accruals of $3.4 million, partially offset by increased inventories of $5.3 million and increased accounts receivable of $2.1 million. $4.0 million of the inventory increase and all of the accounts receivable is attributable to operations at our new Mankato facility.
Net cash used in operating activities for the nine months ended September 30, 2011 was $2.2 million. The cash flow used in operations for the nine months ended September 30, 2011 is primarily the result of working capital requirements needed to support the Mankato operations, which included the purchase of approximately $4.0 million of inventory. Beginning in the third quarter of 2011, we are back to generating cash from operating activities. The cash provided from operating activities for the three months ended September 30, 2011 was $2.5 million, mainly attributed to an increase in accounts payable of $2.2 million resulting from extending terms with our large suppliers.
Net cash used in investing activities of $1.6 million for the nine months ended September 30, 2011 is comprised of $0.6 million in property and equipment purchases to support the business and $1.0 million for the Mankato operation acquisition (see Note 6).
Net cash provided by financing activities for the nine months ended September 30, 2011 was $3.6 million, mainly due to the increase in borrowing on the line of credit and notes payable of $5.0 million, in the aggregate, required to fund the Mankato acquisition and growth, partially offset by debt payments of $1.4 million.
Critical Accounting Policies and Estimates
Our significant accounting policies and estimates are summarized in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2010. There have been no significant changes in these critical accounting policies since December 31, 2010. Some of our accounting policies require us to exercise significant judgment in selecting the appropriate assumptions for calculating financial estimates. Such judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, known trends in our industry, terms of existing contracts and other information from outside sources, as appropriate. Actual results could differ from these estimates.
Forward-Looking Statements:
Those statements in the foregoing report that are not historical facts are forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements generally will be accompanied by words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “possible,” “potential,” “predict,” “project,” or other similar words that convey the uncertainty of future events or outcomes. Although we believe these forward-looking statements are reasonable, they are based upon a number of assumptions concerning future conditions, any or all of which may ultimately prove to be inaccurate. Forward-looking statements involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation:
- Volatility in the marketplace which may affect market supply and demand for our products;
- Increased competition;
- Changes in the reliability and efficiency of operating facilities or those of third parties;
- Risks related to availability of labor;
- Increase in certain raw material costs such as copper;
- Commodity and energy cost instability;
- General economic, financial and business conditions that could affect our financial condition and results of operations;
- Successful integration of recent acquisitions
The factors identified above are believed to be important factors (but not necessarily all of the important factors) that could cause actual results to differ materially from those expressed in any forward-looking statement made by us. Unpredictable or unknown factors not discussed herein could also have material adverse effects on forward-looking statements. All forward-looking statements included in this Form 10-Q are expressly qualified in their entirety by the forgoing cautionary statements. We undertake no obligations to update publicly any forward-looking statement (or its associated cautionary language) whether as a result of new information or future events.
Please refer to forward-looking statements and risks as previously disclosed in our report on Form 10-K for the fiscal year ended December 31, 2010.
Controls and procedures
As filed, 1,429 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures:
In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and Executive Vice President and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). Based upon their evaluation of these disclosure controls and procedures, the Chief Executive Officer and Chief Financial Officer have concluded that the disclosure controls and procedures were effective as of the date of such evaluation in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting:
There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2011-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2011-07-01 to 2011-09-30 | $28.3m | us-gaap:SalesRevenueNet |
| Revenue | 9 months2011-01-01 to 2011-09-30 | $85.1m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2011-07-01 to 2011-09-30 | $25.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2011-01-01 to 2011-09-30 | $75.4m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2011-07-01 to 2011-09-30 | $3.3m | us-gaap:GrossProfit |
| Gross profit | 9 months2011-01-01 to 2011-09-30 | $9.7m | us-gaap:GrossProfit |
| Operating income | 3 months2011-07-01 to 2011-09-30 | $420.1k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2011-01-01 to 2011-09-30 | $1.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2011-07-01 to 2011-09-30 | $130.2k | us-gaap:InterestExpense |
| Interest expense | 9 months2011-01-01 to 2011-09-30 | $392.2k | us-gaap:InterestExpense |
| Income tax | 3 months2011-07-01 to 2011-09-30 | $98.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2011-01-01 to 2011-09-30 | $435.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2011-07-01 to 2011-09-30 | $182.9k | us-gaap:NetIncomeLoss |
| Net income | 9 months2011-01-01 to 2011-09-30 | $955.1k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2011-07-01 to 2011-09-30 | $0.07 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2011-01-01 to 2011-09-30 | $0.35 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted shares (weighted) | 3 months2011-07-01 to 2011-09-30 | 2,742,992 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2011-01-01 to 2011-09-30 | 2,742,992 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2011-01-01 to 2011-09-30 | −$2.2m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months2011-01-01 to 2011-09-30 | $560.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2011-09-30 | $0 | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2011-09-30 | $40.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2011-09-30 | $50.0m | us-gaap:Assets |
| Current liabilities | At period end2011-09-30 | $28.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2011-09-30 | $29.8m | us-gaap:Liabilities |
| Long-term debt | At period end2011-09-30 | $836.7k | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2011-09-30 | $2.1m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2011-09-30 | $20.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-11-060909. Last ingested by Listed: Nov 12, 2026, 19:20 ET. Listed shows no prices and gives no investment advice.